Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New anti-human papilloma virus (HPV) and endometritis preparation

An anti-human papilloma and endometrium technology, applied in the direction of antiviral agents, medical preparations containing active ingredients, antibodies, etc., can solve problems such as no therapeutic effect, and achieve enhanced phagocytosis, elimination of endometrial inflammation, and antibacterial effects. Active stabilization effect

Inactive Publication Date: 2014-09-24
安能(广州)科学技术有限公司
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although some countries such as the United States have developed HPV vaccines, it has been proved by a large number of clinical trials that the effect of preventing HPV virus infection can reach 100% for people who have not been infected with HPV virus after 3 injections; Infection is only preventive and has no curative effect. It is powerless to inject this vaccine for people who have been infected by HPV virus
Moreover, there is not yet enough evidence to show that this vaccine can give injectors life-long immunity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New anti-human papilloma virus (HPV) and endometritis preparation
  • New anti-human papilloma virus (HPV) and endometritis preparation
  • New anti-human papilloma virus (HPV) and endometritis preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0034] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

[0035]

[0036] Since the selection of auxiliary materials is determined according to different dosage forms specified, and these belong to the existing conventional technology, they will not be described in detail here.

[0037] We carry out the detection of activity and drug property to each embodiment:

[0038] Experiment 1

[0039] Carry out ELISA (enzyme-linked immunoassay) with 0.1g / ml of Example 1, and use the principle of antigen-antibody specific immun...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a new anti-human papilloma virus (HPV) and endometritis preparation comprising the following components by weight: 0.0001-10 parts of plant antiviral protein-D, 0.0001-50 parts of anti-HPV IgY, 1-15 parts of composite plant enzyme and 1-80 parts of accessories, the new preparation has the anti-human papilloma virus (HPV) and endometritis elimination effects, has the effects of resistance to infection of a variety of viral diseases and bacterial infection, and has no toxic and side effect.

Description

technical field [0001] The invention relates to the field of biological preparations, in particular to a novel preparation capable of resisting human papillomavirus and endometrium inflammation. Background technique [0002] On the basis of a large number of experimental studies, modern medicine has confirmed that cervical cancer is derived from a human papillomavirus (HPV), which is the only cancer with a clear etiology among all human cancers. Human papillomavirus (HPV) is a large family with more than 100 types, of which about 30 types can cause persistent infection of male and female genitals. Low-risk types of HPV can cause the formation of genital warts, which are fleshy, noncancerous growths on or around the genitals, with types 6 and 11 causing genital warts in 90% of all cases. High-risk types of HPV viruses include types 16, 18, 31, and 45 and other types. If the infection persists for a long time, it will cause cervical cancer, vaginal cancer, and vulvar cancer. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/42A61P31/20A61P15/00A61P31/04A61P31/12A61K38/43A61K38/16
Inventor 熊云峰
Owner 安能(广州)科学技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com